Rockwell Medical, Inc. (NASDAQ:RMTI) headquartered in Wixom, will host a conference call for the investment community to discuss the 3Q20 earnings result on 9th November 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.rockwellmed.com
Earnings Expectation
Rockwell Medical, Inc. is expected to report third quarter earnings results, after market close, on Monday 9th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.1 per share from revenue of $ 15.67 million. Looking ahead, the full year loss are expected at $ 0.4 per share on the revenues of $ 66.61 million.
Rockwell Medical, Inc. operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
